1Hornung V,Rothenfusser S, Britsch S, et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol, 2002, 168(9): 4531-4537.
3Pulendran B, Kumar P, Cutler CW, et al. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol, 2001, 167(9): 5067-5076.
4Leithauser F, Trobonjaca Z, Moller P, et al. Clustering of colonic lamina propria CD4(+) T cells to subepithelial dendritic cell aggregates precedes the development of colitis in a murine adoplive transfer model. Lab Invest, 2001, 81(10): 1339-1349.
5Stagg AJ, Hart AL, Knight SC, et al. The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut,2003, 52(10): 1522-1529.
6Baumgart DC, Metzke D, Schmitz J, et al. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut, 2005, 54(2): 228-236.
7Ohkawara T, Miyashita K, Nishihira J, et al. Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis. Clin Exp Immunol, 2005, 140(2): 241-248.
8Murakami H, Akbar SM, Matsui H, et al. Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest, 2001, 31(4): 337-343.
9Murakami H, Akbar SM, Matsui H, et al. Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitis. Clin Exp Immunol, 2002, 128(3): 504-510.
10Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis.Gastroenterology, 1998, 115(1): 182-205.
